Category: Health Policy

Trade agreements and generics: TRIPS and patent policy explained

Posted by: Lesley Williams in: Health Policy

30 Mar | 02:29 AM

Explore how the TRIPS agreement shapes generic medicine access globally. Learn about patent laws, compulsory licensing, and the balance between innovation and public health.

Pharmacist Guide to Patient Counseling on Generic Medications

A professional guide for pharmacists on effectively counseling patients about generic medications, improving adherence, and meeting legal requirements.

Chest Pain Evaluation: When to Go to the Emergency Department

Not sure if your chest pain is a heart attack or heartburn? Learn the red flags, the HEART score, and exactly when to call emergency services.

Herbal Supplements and Drug Interactions: A Guide to Medication Safety

Learn how herbal supplements can dangerously interact with prescription drugs via CYP450 enzymes. Discover high-risk herbs and how to stay safe.

How Bioequivalence Studies Work: A Step-by-Step Guide to Generic Drug Testing

A comprehensive step-by-step guide on how bioequivalence studies are conducted to ensure generic drugs are safe and effective alternatives to brand-name versions.

First Generic vs Authorized Generic: Market Entry Timing and Strategy

Explore the strategic battle between first generics and authorized generics in the U.S. market, focusing on the 180-day exclusivity window and market entry timing.

Category: Health Policy

Trade agreements and generics: TRIPS and patent policy explained

recent posts

categories

archives

tags